Daiichi Sankyo

AZ and Daiichi to file new breast cancer drug after trial success
Pharmaforum
Wed, 05/8/19 - 10:05 am
AstraZeneca
Daiichi Sankyo
trastuzumab deruxtecan
antibody-drug conjugate
Daiichi picks immuno-oncology bispecific, triggering payout to Zymeworks
Fierce Biotech
Thu, 04/25/19 - 11:45 am
Daiichi Sankyo
immuno-oncology
Zymeworks
bispecific antibodies
AstraZeneca pays up to $6.9 billion in Daiichi Sankyo cancer deal
Yahoo/Reuters
Fri, 03/29/19 - 10:06 am
AstraZeneca
Daiichi Sankyo
breast cancer
trastuzumab deruxtecan
Doubling down on R&D, Daiichi makes executive changes across its U.S. research unit
Fierce Biotech
Fri, 02/22/19 - 11:46 am
R&D
Daiichi Sankyo
Daiichi gets speedy FDA review for rare cancer drug
Pharmaforum
Fri, 02/8/19 - 09:38 am
Daiichi Sankyo
FDA
pexidartinib
TGCT
priority review
Daiichi Sankyo takes option on diabetes stem cell start-up
Pharmaforum
Sat, 01/12/19 - 11:30 am
Daiichi Sankyo
stem cells
Tokyo Institute of Technology
type 1 diabetes
OiDE BetaRevive
Daiichi Sankyo lines up a $900M deal for rights to a cholesterol drug looking to disrupt a blockbuster market
Endpoints
Fri, 01/4/19 - 09:20 am
Daiichi Sankyo
Esperion Therapeutics
Daiichi Sankyo signs clinical trial collaboration deal with Merck and Pfizer
Pharmaceutical Business Review
Fri, 10/26/18 - 09:52 am
Daiichi Sankyo
Merck
Pfizer
clinical trials
DS-8201
solid tumors
Daiichi Sankyo launches phase 1 trial of DS-1205 in EGFR-mutated NSCLC
Pharmaceutical Business Review
Fri, 10/19/18 - 10:53 pm
Daiichi Sankyo
non-small cell lung cancer
DS-1205
Encouraging trial results for Daiichi anti-stroke therapy
The Pharma Letter
Fri, 05/18/18 - 09:41 pm
Daiichi Sankyo
Lixiana
edoxaban
clinical trials
atrial fibrilation
stroke
Daiichi Sankyo in pursuit of Novartis’ Rydapt with next-generation FLT3 drug
Fierce Biotech
Wed, 05/9/18 - 09:21 am
Novartis
Rydapt
acute myeloid leukemia
Daiichi Sankyo
quizartinib
Daiichi Sankyo concedes an early setback on Duchenne MD drug, but doubles down on development
Endpoints
Wed, 04/25/18 - 09:50 am
Daiichi Sankyo
Duchenne Muscular Dystrophy
DS-5141
Could This be the End of Flu Shots?
CP Wire
Fri, 04/20/18 - 09:18 am
Vaxart
influenza vaccines
Daiichi Sankyo
vaccines
oral vaccines
Could This be the End of Flu Shots? - Updated
Fri, 04/20/18 - 11:52 am
Vaxart
influenza vaccines
Daiichi Sankyo
Top 5 boards for week ending March 10, 2018
CP Wire
Sun, 03/11/18 - 03:05 pm
Daiichi Sankyo
Shire
Amgen
Sanofi
AstraZeneca
3 Things In Biotech, March 8: A Tale Of 3 New Trials
Seeking Alpha
Sat, 03/10/18 - 09:26 am
biotech
clinical trials
Seattle Genetics
SGN-CD48A
Daiichi Sankyo
DS-8201
HER-positive colorectal cancer
Allena Pharmaceuticals
hyperoxaluria
Top 5 viewed boards for week ending March 3, 2018
CP Wire
Sun, 03/4/18 - 01:50 pm
cafepharma
Daiichi Sankyo
Shire
Allergan
Amgen
Sanofi
sales meeting
layoffs
Esmya
Pfizer
Celgene
M&A
Daiichi Sankyo douses a report about an AstraZeneca buyout offer
Endpoints
Thu, 08/31/17 - 09:28 am
AstraZeneca
Daiichi Sankyo
M&A
Daiichi Sankyo punts $650M collaboration pact as Charleston Labs preps a comeback attempt on spurned pain drug
Endpoints
Thu, 08/31/17 - 09:13 am
Daiichi Sankyo
Charleston Laboratories
CL-108
painkillers
Daiichi Sankyo hands off cancer drug to Boston Pharma
BioPharma Dive
Wed, 08/30/17 - 09:58 am
Boston Pharmaceuticals
Daiichi Sankyo
DS-5010
cancer

Pages